NIH Hides Brain Grant Drama Behind Closed Virtual Doors
Published Date: 3/25/2025
Notice
Summary
The National Institute of Neurological Disorders and Stroke is holding a closed virtual meeting on April 28-29, 2025, to review important grant applications. This meeting affects researchers seeking funding for brain and nerve disorder studies and keeps sensitive info private. No money changes now, but decisions made here will shape future research support.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Closed grant review for neurology
The National Institute of Neurological Disorders and Stroke will hold a closed virtual meeting on April 28-29, 2025, from 9:00 a.m. to 7:00 p.m. to review and evaluate grant applications for neurological research. If you are a researcher seeking NIH grant support for neurological studies, this meeting affects which applications are evaluated for future research support.
Applicant confidentiality preserved
The meeting will be closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, commercial property (including patentable material), and personal information in grant applications. This keeps sensitive commercial and personal details private during the April 28-29, 2025 virtual review.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14964, Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a closed virtual meeting on August 19, 2026, to review neuroscience career development grant applications. This meeting is private to protect sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as funding decisions could impact their projects and careers.
Previous / Next Documents
Previous: 2025-05029, Notice of Public Meetings of the Colorado Advisory Committee to the U.S. Commission on Civil Rights
The Colorado Advisory Committee to the U.S. Commission on Civil Rights is holding two important meetings in April 2025. They’ll pick a study topic on April 2 and then approve a project plan and start organizing hearings on April 16. These meetings affect anyone interested in civil rights in Colorado and help shape future actions without any direct cost to the public.
Next: 2025-05034, Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Previously Approved Collection; Application for Registration-DEA Form 225, Application for Registration Renewal-DEA Form 225a, Affidavit for Chain Renewal-DEA Form 225b
The DEA is asking to keep using and update some important forms for drug registration and renewals, like DEA Form 225 and its cousins. This affects businesses and people who handle controlled substances, making sure their paperwork stays current without extra hassle. They’re aiming to keep things smooth and on time, with no new fees or surprises.